bioAffinity Technologies Reports Q2 2026 Results

What Happened
bioAffinity Technologies, Inc. filed a Form 8-K on August 7, 2026 (Item 2.02) to furnish a press release that includes financial information for the second quarter ended June 30, 2026. The press release is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: August 7, 2026; reporting period: quarter ended June 30, 2026.
• The company issued a press release containing its quarterly financial information (attached as Exhibit 99.1 to the 8-K).
• The 8-K specifically furnishes results of operations and financial condition (Item 2.02).

Why It Matters
This filing signals that bioAffinity has publicly reported its Q2 2026 quarterly results to the SEC and investors. Retail investors should review the attached press release (Exhibit 99.1) for detailed figures on revenue, earnings, cash flow, and any management commentary that could affect the stock or near-term expectations.